About Index Trending news
Lists
Pricing
ImmunoPhotonics

ImmunoPhotonics

ImmunoPhotonics

Developing a novel immunotherapy inCVAX, a minimally invasive vaccine that intends to cause a systemic antitumor response to treat late-stage metastatic cancers

Elsewhere

Alexa global traffic share

Twitter followers

03 Sep 2014
$1,800,000
Venture capital (Series A)